The Ask
Drive urgency to protect infants through Respiratory Syncytial Virus (RSV) season and build awareness of the first monoclonal antibody treatment to be routinely used for it.
Sanofi RSV
Drive urgency to protect infants through Respiratory Syncytial Virus (RSV) season and build awareness of the first monoclonal antibody treatment to be routinely used for it.
90% of babies are infected with RSV before they reach the age of 2, and 40% of all parents interested in vaccine education are ²ÝÝ®ÊÓƵÔÚÏß¹Û¿´18 readers.
The Solution
²ÝÝ®ÊÓƵÔÚÏß¹Û¿´18 Studios leveraged its robust parenting portfolio to educate parents and caregivers on RSV, driving traffic to educational resources about RSV and disease prevention. This included a Spanish version of a custom article to ensure the message reached the widest audience possible.
